Cargando…
A New Signature That Predicts Progression-Free Survival of Clear Cell Renal Cell Carcinoma with Anti-PD-1 Therapy
Immunotherapy has greatly improved the survival time and quality of life of patients with renal cell carcinoma, but the benefits are limited to a small portion of patients. There are too few new biomarkers that can be used to identify molecular subtypes of renal clear cell carcinoma and predict surv...
Autores principales: | Lin, Jingwei, Cai, Yingxin, Ma, Yuxiang, Pan, Jinyou, Wang, Zuomin, Zhang, Jianpeng, Liu, Yangzhou, Zhao, Zhigang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10049491/ https://www.ncbi.nlm.nih.gov/pubmed/36982415 http://dx.doi.org/10.3390/ijms24065332 |
Ejemplares similares
-
Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy
por: Cai, Yingxin, et al.
Publicado: (2022) -
Novel biomarkers predict prognosis and drug-induced neuroendocrine differentiation in patients with prostate cancer
por: Lin, Jingwei, et al.
Publicado: (2023) -
COVID-19 inhibits spermatogenesis in the testes by inducing cellular senescence
por: Wang, Zuomin, et al.
Publicado: (2023) -
Methylation Signature for Prediction of Progression Free Survival in Surgically Treated Clear Cell Renal Cell Carcinoma
por: Kang, Ho Won, et al.
Publicado: (2019) -
Epigenetic signature predicts overall survival clear cell renal cell carcinoma
por: Wang, Yejinpeng, et al.
Publicado: (2020)